Unique ID issued by UMIN | UMIN000049532 |
---|---|
Receipt number | R000056400 |
Scientific Title | Epidemiological study of chronic obstructive pulmonary disease (COPD) using health insurance claims data and health examination data |
Date of disclosure of the study information | 2022/11/16 |
Last modified on | 2024/05/19 17:13:51 |
Epidemiological study of chronic obstructive pulmonary disease (COPD) using health insurance claims data and health examination data
Epidemiological study of COPD using health insurance claims data and health examination data
Epidemiological study of chronic obstructive pulmonary disease (COPD) using health insurance claims data and health examination data
Epidemiological study of COPD using health insurance claims data and health examination data
Japan |
chronic obstructive pulmonary disease
Pneumology |
Others
NO
Using health insurance claims data and health examination data, we will investigate the epidemiology of COPD and the characteristics of those with airflow limitation, and the relationship between COPD and frailty and anemia.
Others
Epidemiology
Others
Others
Not applicable
Prevalence of airflow limitation and COPD diagnosis rate
- Percentage of patients by severity of airflow limitation using %FEV1
- FEV1%, FEV1, prevalence of disease, and prescription drugs by COPD diagnosis
- FEV1%, FEV1, and prevalence of disease by frailty classification
- FEV1% and FEV1 by COPD diagnosis and smoking status over 3 years
Observational
40 | years-old | <= |
Not applicable |
Male and Female
Target Group (1)
(i) Have had at least one medical checkup between January 2017 and December 2019
(ii) Enrolled for one year in the year of the checkup
(iii) Aged 40 years or older at the time of the checkup
(iv) FEV1% and FEV1 have been measured
Target Group (2)
(i) Have a medical checkup in each year (3 years) from January 2017 to December 2019
(ii) Have been enrolled for three years from January 2017
(iii) Aged 40 years or older as of January 2017
(iv) Have airflow limitation as of 2017
(v) Have had FEV1% and FEV1 measured continuously for 3 years
No setting
60000
1st name | Yuka |
Middle name | |
Last name | Koga |
Kracie, Ltd.
Pharmaceutical Research Promotion Department, Pharmaceutical Division
108-8080
3-20-20, Kaigan, Minato-ku, Tokyo, Japan
03-5446-3352
koga_yuka@kracie.co.jp
1st name | Yuka |
Middle name | |
Last name | Koga |
Kracie, Ltd.
Pharmaceutical Research Promotion Department, Pharmaceutical Division
108-8080
3-20-20, Kaigan, Minato-ku, Tokyo, Japan
03-5446-3352
koga_yuka@kracie.co.jp
Kracie, Ltd.
Kracie, Ltd.
Profit organization
JMDC Inc
Kyoyukai RiverSide Clinic
2-1 west, 7 South, Chuo-ku, Sapporo, Hokkaido
011-521-2321
rinrishinsa@riversideclinic.or.jp
NO
2022 | Year | 11 | Month | 16 | Day |
Partially published
100000
Completed
2022 | Year | 09 | Month | 12 | Day |
2020 | Year | 08 | Month | 30 | Day |
2022 | Year | 10 | Month | 18 | Day |
2022 | Year | 12 | Month | 31 | Day |
Cross-sectional study and past-origin cohort study using the JMDC database
2022 | Year | 11 | Month | 16 | Day |
2024 | Year | 05 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056400